Two Sigma Investments, LP Mirati Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $3.9 Million - $8.83 Million	-99,577 Reduced 44.4%	124,700 $8.37 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $17 Million - $33.9 Million	224,277 New	224,277 $18.4 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $24.9 Million - $31.1 Million	-173,216 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $1.36 Million - $1.9 Million	8,560 Added 5.2%	173,216 $29.7 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $25.4 Million - $37.7 Million	156,746 Added 1981.62%	164,656 $36.2 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $69,088 - $102,034	610 Added 8.36%	7,910 $1.31 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $525,673 - $878,847	7,300 New	7,300 $833,000
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $1.38 Million - $2.3 Million	-19,750 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $2.17 Million - $3.96 Million	-30,731 Reduced 60.88%	19,750 $2.55 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $275,022 - $386,888	3,530 Added 7.52%	50,481 $3.93 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $2.79 Million - $4.92 Million	46,951 New	46,951 $4.84 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $565,200 - $752,400	-12,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $312,600 - $628,800	12,000 New	12,000 $592,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.